Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

Walgreens Boots Alliance Inc Stock Research

WBA

22.54USD+0.12(+0.54%)Market Closed
Watchlist

Market Summary

USD22.54+0.12
Market Closed
0.54%

WBA Stock Price

WBA RSI Chart

WBA Valuation

Market Cap

19.4B

Price/Earnings (Trailing)

-5.84

Price/Sales (Trailing)

0.14

EV/EBITDA

-5.9

Price/Free Cashflow

-23.57

WBA Price/Sales (Trailing)

WBA Profitability

EBT Margin

-4.08%

Return on Equity

-14.84%

Return on Assets

-3.13%

Free Cashflow Yield

-4.24%

WBA Fundamentals

WBA Revenue

Revenue (TTM)

136.1B

Revenue Y/Y

8.64%

Revenue Q/Q

1.59%

WBA Earnings

Earnings (TTM)

-3.3B

Earnings Y/Y

-59.17%

Earnings Q/Q

-83.21%

Price Action

52 Week Range

20.5841.74
(Low)(High)

Last 7 days

5.1%

Last 30 days

-4.3%

Last 90 days

-22.7%

Trailing 12 Months

-26.8%

WBA Financial Health

Current Ratio

0.63

WBA Investor Care

Buy Backs (1Y)

0.10%

Diluted EPS (TTM)

-3.84

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for WBA

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-06-30
DRISCOLL JOHN PATRICK
bought
146,984
28.4191
5,172
evp, pres. u.s. healthcare
2023-06-01
Gray Danielle
acquired
-
-
32,982
evp and global clo
2023-06-01
May Holly
acquired
-
-
32,982
evp, global chief hr officer
2023-05-01
Kehoe James
sold (taxes)
-212,205
35.25
-6,020
evp and global cfo
2023-04-18
Kehoe James
acquired
-
-
18,833
evp and global cfo
2023-03-29
BREWER ROSALIND G
bought
339,510
33.951
10,000
ceo
2023-03-15
BREWER ROSALIND G
sold (taxes)
-842,270
33.29
-25,301
ceo
2022-11-18
Ban Kevin M.
acquired
350,714
34.04
10,303
evp, chief medical officer
2022-11-18
Ban Kevin M.
sold
-414,108
40.193
-10,303
evp, chief medical officer
2022-11-17
SCHLICHTING NANCY M
sold
-660,928
39.887
-16,570
-

1–10 of 50

Which funds bought or sold WBA recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-09-26
M Holdings Securities, Inc.
sold off
-100
-1,149,000
-
-%
2023-09-21
Jefferies Group LLC
added
603
4,812,840
5,810,440
0.05%
2023-09-21
Baystate Wealth Management LLC
added
14.02
-1,825
28,050
-%
2023-09-20
BARCLAYS PLC
added
50.37
13,424,000
69,617,000
0.04%
2023-09-12
Farther Finance Advisors, LLC
added
27.57
2,592
53,390
0.01%
2023-09-08
TUCKER ASSET MANAGEMENT LLC
reduced
-97.92
-1,632
28.00
-%
2023-09-07
ST GERMAIN D J CO INC
new
-
60,399
60,399
-%
2023-08-30
CHAPIN DAVIS, INC.
sold off
-100
-205,441
-
-%
2023-08-30
Western Wealth Management, LLC
sold off
-100
-343,606
-
-%
2023-08-28
DT Investment Partners, LLC
added
0.1
-242,064
1,429,950
0.16%

1–10 of 47

Latest Funds Activity

Are funds buying WBA calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own WBA
No. of Funds

Schedule 13G FIlings of Walgreens Boots Alliance

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 09, 2023
vanguard group inc
7.13%
61,519,967
SC 13G/A
Feb 07, 2023
state street corp
6.68%
57,573,619
SC 13G/A
Jan 31, 2023
blackrock inc.
7.0%
60,606,871
SC 13G/A
Feb 14, 2022
state street corp
5.45%
47,095,044
SC 13G/A
Feb 07, 2022
blackrock inc.
6.4%
55,032,519
SC 13G/A
Feb 11, 2021
state street corp
5.43%
46,922,371
SC 13G
Feb 10, 2021
vanguard group inc
6.72%
58,059,957
SC 13G/A
Feb 01, 2021
blackrock inc.
5.8%
49,962,675
SC 13G/A
Jul 27, 2020
alliance sante participations s.a.
16.7%
144,788,821
SC 13D/A
Feb 14, 2020
state street corp
5.26%
46,702,228
SC 13G

Recent SEC filings of Walgreens Boots Alliance

View All Filings
Date Filed Form Type Document
Sep 22, 2023
8-K/A
Current Report
Sep 01, 2023
8-K
Current Report
Aug 10, 2023
8-K
Current Report
Aug 07, 2023
SC 13D/A
13D - Major Acquisition
Aug 07, 2023
4
Insider Trading
Aug 07, 2023
3
Insider Trading
Jul 27, 2023
8-K
Current Report
Jul 14, 2023
8-K
Current Report
Jul 14, 2023
4
Insider Trading
Jul 14, 2023
4
Insider Trading

Peers (Alternatives to Walgreens Boots Alliance)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
431.3B
630.8B
-0.91% 24.41%
30.72
0.68
7.31% 1.25%
253.2B
235.4B
4.97% 21.19%
42.2
1.08
8.23% 6.27%
33.1B
76.3B
-7.27% -7.22%
18.7
0.43
11.20% 30.27%
31.6B
148.8B
-4.24% 1.20%
12.4
0.21
5.41% 16.48%
19.4B
136.1B
-4.31% -26.80%
-5.84
0.14
1.18% -161.63%
9.5B
19.4B
8.11% -2.43%
18.73
0.49
6.47% 4.02%
MID-CAP
10.1B
14.5B
11.74% 34.43%
21.88
0.7
2.00% 23.94%
9.1B
35.0B
-3.91% 47.81%
19.54
0.26
8.81% 137.76%
4.3B
6.6B
6.68% 51.35%
16.87
0.65
5.67% 1.58%
2.8B
3.8B
-6.22% -13.88%
39.56
0.74
16.58% 29.09%
1.7B
4.8B
-3.07% -12.43%
14.21
0.35
8.40% -0.97%
SMALL-CAP
1.7B
16.8B
-2.63% 63.45%
19.89
0.1
10.44% -34.14%
823.1M
3.1B
-26.78% -28.37%
39.73
0.27
38.67% -31.40%
26.7M
23.7B
-37.91% -90.51%
-0.03
0
-2.83% -48.91%

Walgreens Boots Alliance News

StreetInsider.com
Form FWP BANK OF MONTREAL /CAN/ Filed by: BANK OF ....
StreetInsider.com,
62 minutes ago
London South East
StreetInsider.com
Nasdaq

Returns for WBA

Cumulative Returns on WBA

-6.4%


10-Year Cumulative Returns

-14.0%


7-Year Cumulative Returns

-18.4%


5-Year Cumulative Returns

-11.3%


3-Year Cumulative Returns

Risks for WBA

What is the probability of a big loss on WBA?

82.7%


Probability that Walgreens Boots Alliance stock will be more than 20% underwater in next one year

54.6%


Probability that Walgreens Boots Alliance stock will be more than 30% underwater in next one year.

23.9%


Probability that Walgreens Boots Alliance stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does WBA drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Walgreens Boots Alliance was unfortunately bought at previous high price.

Drawdowns

Financials for Walgreens Boots Alliance

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Revenue2.1%136,108133,290132,184132,703134,516135,949134,972132,509128,618124,952123,509121,983125,566129,793132,985136,866136,354136,097134,590131,537128,244
Gross Profit0.1%27,00626,99027,64328,26429,35729,93829,01128,06726,88825,69425,93026,07726,98128,47529,21230,07630,42330,75031,09230,79230,557
  S&GA Expenses0.3%34,53534,43134,06227,29526,62525,72225,18624,58623,71025,47825,35825,43624,77823,12923,54023,55725,06325,06325,06424,69424,757
EBITDA100.0%--2,954-2,6916,3757,7298,9548,9884,8734,2381,2001,3893,0123,2746,4186,7097,101-----
EBITDA Margin100.0%--0.02*-0.02*0.05*0.06*0.07*0.07*0.04*0.03*0.01*0.01*0.02*0.02*0.05*0.05*0.05*-----
Interest Expenses14.0%529464423400382819856905968571590613591630655650688658628616650
Earnings Before Taxes-6.7%-5,803-5,439-5,0993,9855,6506,4176,4161,9951,590-1,021-9594465683,6283,9764,3595,4805,7226,2045,9755,246
EBT Margin100.0%--0.04*-0.04*0.03*0.04*0.05*0.05*0.02*0.01*-0.01*-0.01*0.00*0.00*0.03*0.03*0.03*-----
Net Income-5.4%-3,315-3,144-2,9644,3375,3796,2876,4302,5422,288-617-6974567603,4933,7033,9814,8165,1335,3265,0244,314
Net Income Margin100.0%--0.02*-0.02*0.03*0.04*0.05*0.05*0.02*0.02*0.00*-0.01*0.00*0.01*0.03*0.03*0.03*-----
Free Cashflow-100.0%-9821,4032,1653,4393,6264,0574,1764,9834,1954,2004,1104,3595,2694,5763,892-----
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Assets-1.9%98,605100,47992,87590,12492,75992,68396,50781,28591,92090,92089,16787,17486,44490,00390,80767,59868,58670,43469,94168,12470,152
  Current Assets-6.5%16,54217,68919,52316,90218,87216,82420,31415,81426,60726,08421,08418,07318,32618,90919,60418,70019,02119,85120,08317,84619,988
    Cash Equivalents-19.9%8711,0882,3491,3584,5412,0274,2681,2701,8031,3111,3397469439881,0001,2077687921,1839752,074
  Inventory-6.8%8,1648,7579,3228,3538,5208,9479,4758,1598,3338,54111,1807,9179,5639,65210,5369,3339,87410,18810,9769,5659,889
  Net PPE--------------13,48213,62013,47813,71713,82813,82113,91113,938
  Goodwill30738.0%28,37192.0022,58222,28021,90121,9588,16612,42112,49312,46815,29912,01314,94816,78816,80013,54216,71717,02716,80916,914-
Liabilities-2.5%69,08670,88268,13759,71761,60261,00463,14157,14569,01468,98568,42666,038---------
  Current Liabilities-7.3%26,17028,22828,03622,58324,06722,69924,44722,05434,47531,24630,37927,07026,64928,66229,49425,76925,06025,30325,09921,66721,482
  Short Term Borrowings-27.5%3,0614,2223,9381,0592,7872,1052,6471,3057,9635,1615,2453,2654,3795,9846,2255,7385,4835,3564,3441,9662,587
    LT Debt, Non Current0.2%8,8418,8207,78910,61510,67011,20311,1997,6757,73210,99810,97312,20312,11110,62510,62811,09812,12712,68511,64612,43112,456
Shareholder's Equity-28.5%21,06329,43924,58225,27530,38230,86730,57923,82222,59621,62520,56321,13621,32324,33424,31424,15224,77125,41326,26326,68928,470
  Retained Earnings-0.9%33,65433,95233,66437,80138,63238,75738,28635,12134,90834,11633,49534,21034,24436,35135,81035,81535,54734,92834,16833,55132,460
  Additional Paid-In Capital0.4%10,66710,62910,47710,95011,02910,97310,96610,98810,97110,91610,87610,76110,72610,68910,64810,63910,60510,57110,52210,49310,444
Shares Outstanding0.1%863863864-864---864,700864,200---885891-910928948-992
Minority Interest0.6%8,2968,2474,0064,091--4,316402495514506498586615653641638643654682734
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Cashflow From Operations-55.8%1,3052,9543,2933,8995,0585,1835,4595,5556,3965,5565,6185,4845,7776,8836,1955,5946,0326,2507,7208,2637,464
  Share Based Compensation-8.0%473514578391301255154155156140145137133123120119126130132130111
Cashflow From Investing-23.7%-3,051-2,4662,752-1,0644,1513,2472,3734,072-1,978-2,036-1,154-1,297-1,398-1,878-2,074-2,307-1,959-2,391-5,537-5,501-5,502
Cashflow From Financing-234.5%-1,679-502-5,975-1,499-6,427-7,620-4,807-9,036-3,505-3,209-4,133-4,647-4,472-5,017-4,303-3,047-5,085-4,794-3,048-5,295-12,384
  Dividend Payments-0.2%1,6521,6551,6611,6591,6561,6421,6251,6171,6991,6981,7421,7471,6591,6591,6311,6431,6921,7651,7481,7391,786
  Buy Backs0%1501501831871871871541103257861,2261,5891,8081,9603,7214,1606,4295,8163,6155,2286,288

WBA Income Statement

2023-05-31
CONSOLIDATED CONDENSED STATEMENTS OF EARNINGS - USD ($)
shares in Millions, $ in Millions
3 Months Ended9 Months Ended
May 31, 2023
May 31, 2022
May 31, 2023
May 31, 2022
Income Statement [Abstract]    
Sales$ 35,415$ 32,597$ 103,659$ 100,254
Cost of sales28,82626,02583,06278,399
Gross profit6,5886,57220,59621,855
Selling, general and administrative expenses7,1237,01927,21519,975
Equity earnings in AmerisourceBergen58127187330
Operating (loss) income(477)(320)(6,431)2,209
Other income, net2684101,8122,829
(Loss) earnings before interest and income tax (benefit) provision(209)90(4,619)5,038
Interest expense, net173108425295
(Loss) earnings before income tax (benefit) provision(382)(18)(5,044)4,743
Income tax (benefit) provision(330)(242)(1,707)205
Post-tax earnings from other equity method investments451829
Net (loss) earnings(48)229(3,320)4,566
Net loss attributable to non-controlling interests(166)(60)(420)(186)
Net earnings (loss) attributable to Walgreens Boots Alliance, Inc.$ 118$ 289$ (2,900)$ 4,752
Net earnings (loss) per common share:    
Basic (in dollars per share)$ 0.14$ 0.33$ (3.36)$ 5.50
Diluted (in dollars per share)$ 0.14$ 0.33$ (3.36)$ 5.49
Weighted average common shares outstanding:    
Basic (in shares)863.1864.0863.1864.4
Diluted (in shares)863.8865.3863.1866.0

WBA Balance Sheet

2023-05-31
CONSOLIDATED CONDENSED BALANCE SHEETS - USD ($)
$ in Millions
May 31, 2023
Aug. 31, 2022
Current assets:  
Cash and cash equivalents$ 871$ 1,358
Marketable securities991,114
Accounts receivable, net5,8435,017
Inventories8,1648,353
Other current assets1,5651,059
Total current assets16,54216,902
Non-current assets:  
Property, plant and equipment, net11,56211,729
Operating lease right-of-use assets22,05121,259
Goodwill28,37122,280
Intangible assets, net13,57810,730
Equity method investments (see Note 5)3,5275,495
Other non-current assets2,9731,730
Total non-current assets82,06373,222
Total assets98,60590,124
Current liabilities:  
Short-term debt3,0611,059
Trade accounts payable (see Note 16)12,02911,255
Operating lease obligations2,3562,286
Accrued expenses and other liabilities8,5787,899
Income taxes14684
Total current liabilities26,17022,583
Non-current liabilities:  
Long-term debt8,84110,615
Operating lease obligations22,18121,517
Deferred income taxes1,6571,442
Accrued litigation obligations6,407551
Other non-current liabilities3,8293,009
Total non-current liabilities42,91537,134
Commitments and contingencies (see Note 10)
Total liabilities69,08659,717
Redeemable non-controlling interests1601,042
Equity:  
Preferred stock $.01 par value; authorized 32 million shares, none issued00
Common stock $.01 par value; authorized 3.2 billion shares; issued 1,172,513,618 at May 31, 2023 and August 31, 20221212
Paid-in capital10,66710,950
Retained earnings33,65437,801
Accumulated other comprehensive loss(2,539)(2,805)
Treasury stock, at cost; 309,252,205 shares at May 31, 2023 and 307,874,161 shares at August 31, 2022(20,731)(20,683)
Total Walgreens Boots Alliance, Inc. shareholders’ equity21,06325,275
Non-controlling interests8,2964,091
Total equity29,35929,366
Total liabilities, redeemable non-controlling interests and equity$ 98,605$ 90,124
Rosalind G. Brewer
65535
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.